about
GliZ, a transcriptional regulator of gliotoxin biosynthesis, contributes to Aspergillus fumigatus virulenceEpidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantationTraumatic brain injury and risk of dementia in older veteransIndividualizing life expectancy estimates for older adults using the Gompertz Law of Human MortalityLack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?Coreactivation of Human Herpesvirus 6 and Cytomegalovirus Is Associated With Worse Clinical Outcome in Critically Ill Adults.Long-term outcomes following positive fecal occult blood test results in older adults: benefits and burdens.Medical center characteristics associated with PSA screening in elderly veterans with limited life expectancy.Symptomatic Respiratory Virus Infection and Chronic Lung Allograft DysfunctionFluconazole coadministration concurrent with cyclophosphamide conditioning may reduce regimen-related toxicity postmyeloablative hematopoietic cell transplantation.Five-year downstream outcomes following prostate-specific antigen screening in older menProbability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold.Sensitivity of blood and tissue diagnostics for gastrointestinal cytomegalovirus disease in solid organ transplant recipients.Prisoner of war status, posttraumatic stress disorder, and dementia in older veterans.Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.Clinical and radiologic factors associated with pulmonary nodule etiology in organ transplant recipientsInvasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantationClinical decision rule for non-traumatic computed tomography of the brain
P50
Q24673051-FBB64134-BB40-406A-9DE0-1611B9705332Q28293483-EF514AE6-E8F4-46FD-9452-FB2AE6C1B6F5Q28391306-F2C8E06E-579B-4D65-BE79-5E12A878E0D9Q34268845-83152BD5-62EC-47E8-A159-BC58C828A3EEQ34494893-B012B6A4-C27E-48B8-8060-7A21802AE09CQ35752239-D10CB33F-A844-417C-BF72-D8F718D08743Q35794227-99A83534-1B37-4963-BB62-34F824E5A424Q35980688-CACCE5A1-FB86-49AA-A0C9-C7D4C660A1D9Q36446117-56F3AEBA-959F-45F0-B65A-F80B3574C662Q36949557-E7D62118-C49F-4761-9D48-33C45F7EAC89Q37017183-6FFB3A3C-0452-4DAF-80CD-47C33A7D873CQ37619443-3756CC60-0837-4B97-835A-ABFC7B585783Q40745065-3B90FF49-D1D2-4AAB-BC6D-98734C51F1A1Q45328852-3D9384E6-553D-478E-BE8D-367CB1E18067Q46395734-F65796ED-43AD-41C3-82B5-59E978B287CFQ79267339-44E555E9-C50A-4054-BD1F-11B77CB867F1Q80078435-021CB492-A307-4804-98E2-3A068986ACA4Q93082912-A95886F0-84D3-46FB-959D-16DA795D518D
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Katharine A Kirby
@ast
Katharine A Kirby
@en
Katharine A Kirby
@es
Katharine A Kirby
@nl
Katharine A Kirby
@sl
type
label
Katharine A Kirby
@ast
Katharine A Kirby
@en
Katharine A Kirby
@es
Katharine A Kirby
@nl
Katharine A Kirby
@sl
prefLabel
Katharine A Kirby
@ast
Katharine A Kirby
@en
Katharine A Kirby
@es
Katharine A Kirby
@nl
Katharine A Kirby
@sl
P106
P21
P31
P496
0000-0003-0876-8113